ArticleJournal of gynecologic oncology2025

Platinum free interval and clinical benefit of the second-line chemotherapy in recurrent uterine and ovarian carcinosarcoma: a retrospective cohort analysis.

Julie Berthet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.